CAS Insights^TM

Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.

袖珍核电池背后的科学。 从为可穿戴设备供电到处理放射性废物，探索贝塔伏特电池的潜力与局限性。

Recycling semiconductors was once a far-off dream. However, new research and technology shows that this could become reality.

Explore the science behind sweeteners, their health impact, and emerging alternatives.

最近举行的癌症与大数据专家网络研讨会揭示了免疫肿瘤学的新兴趋势、数据挑战以及研究人员面临的机遇。

See key insights on emerging RNA IP trends and possibilities for future innovations in this executive summary.

As antimicrobial resistance becomes a larger problem, new approaches to battling infections are emerging.

The landscape of exosomes has become highly competitive. See all the recent investments, innovations, and commercial opportunities.

Experts from Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS discuss major research trends in 2024.

As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.

CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.

Discover how AI in the food industry is transforming production, innovation, and sustainability. Learn how AI can help you create smarter and more efficient food solutions.

Immunotherapy is advancing with new approaches like CAR-T cell therapy, antibody-drug conjugates, and even checkpoint inhibitors.

人工智能重新定义天然产物药物的发现。 了解机器学习技术如何从植物、微生物等中发掘出多种候选药物，从而加快发现速度

抗生素耐药性感染是一场全球性的公共卫生危机。 在与耐药细菌的斗争中，人们需要人工智能、替代疗法和材料创新等新型解决方案。

掌握 2024 年有望加速创新并变革全球科学界的最新科学突破

了解数字化转型如何减少浪费，并通过重新利用废物副产品为公司创造新的收入来源。

在本文中揭示免疫肿瘤学出版物和研究领域的新趋势，确定未来的新机遇和挑战。

The pharma industry is tackling major drug discovery challenges in several new ways. Have they been successful?

在本文中，我们将与 Nicole Stobart、Jeff Wilson 和 Mark Schmidt 讨论 CAS 如何利用权威结构对生物分子进行索引。

制药制造商正在研究如何从暗制剂数据中获得见解，将曾经隐藏的知识转化为药物发现。

随着可持续发展理念的不断深入，涂料生产商正在通过以下 4 种方式将可再生原料用于自有产品之中。

随着药物再利用市场迎来增长，制药公司正在研究如何从配方暗数据中培养见解，将曾经隐藏的见解转化为药物再利用创新。

作为新型药物 Semaglutide（GLP-1 受体激动剂）的组成部分，探索 Ozempic、Wegovy 和 Mounjaro 如何通过调节血糖和食欲，帮助治疗肥胖症和糖尿病。

了解光催化技术如何利用水和太阳能生产清洁氢气，以及为什么光催化技术对去碳化至关重要。 阅览有关此主题的最新研究。